A study in the Journal of the American Medical Association showed that attention-deficit/hyperactivity disorder drugs do not increase the risk of cardiovascular diseases such as myocardial infarction, stroke or sudden cardiac death in young and middle-aged adults. "However, as with any study such as ours, there are limitations to the data and we cannot completely rule out a modestly elevated risk," lead researcher Laurel Habel said.

Full Story:
HealthDay News

Related Summaries